Utama › Limfoma Sel-T › New York › New York City
Kajian klinikal Limfoma Sel-T di New York City, NY
13 kajian untuk Limfoma Sel-T sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- Columbia University, New York
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Mengambil pesertaFasa 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Mengambil pesertaFasa 3
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Cancer Center, New York
CD4CAR for CD4+ Leukemia and Lymphoma
Mengambil pesertaFasa 1
- Albert Einstein Health Network, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering, New York
A Registry for People With T-cell Lymphoma
Mengambil pesertaKajian pemerhatian
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Mengambil pesertaFasa 2
- Icahn School of Medicine at Mount Sinai, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Mengambil pesertaFasa 1
- Columbia University Irving Medical Center, New York
Tissue Repository: CTCL Collection Protocol
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Columbia University Irving Medical Center, New York
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Mengambil pesertaFasa 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Kajian Limfoma Sel-T di bandar lain
- Philadelphia, PA10 kajian
- Baldwin Park, CA9 kajian
- Boston, MA9 kajian
- Houston, TX8 kajian
- Atlanta, GA8 kajian
- Rochester, MN6 kajian
- Columbus, OH6 kajian
- Chicago, IL6 kajian
- Seattle, WA6 kajian
- New Haven, CT5 kajian
- Miami, FL5 kajian
- Scottsdale, AZ4 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.